Table 1 Demographic, immunological, and clinical characteristics of AHD clients provided with advanced disease management package of services, Mumbai (N = 2,779)
Characteristics | n (%) | |
|---|---|---|
Age in years | <20 | 107 (3.9) |
20–39 | 863 (31.1) | |
40–59 | 1632 (58.7) | |
≥ 60 | 177 (6.4) | |
Sex | Male | 1892 (68.1) |
Female | 887 (31.9) | |
Type of population | Key Population | 80 (2.9) |
General Population | 2699 (97.1) | |
WHO clinical stage at enrolment | I | 2045 (73.5) |
II | 349 (12.6) | |
III | 180 (6.5) | |
IV | 205 (7.4) | |
CD4 Count (cells/mm3) at enrolment | ≤ 50 | 214 (7.7) |
51–100 | 471 (16.9) | |
101–200 | 1914 (68.9) | |
> 200 | 180 (6.5) | |
Viral load (copies/ml) at enrolment | < 1000 | 1328 (47.8) |
≥ 1000 | 536 (19.3) | |
Not Available | 915 (32.9) | |
4 symptom (4 S) screening for TB | 4 S Positive | 202 (7.3) |
4 S Negative | 2302 (82.8) | |
Presented with TB | 275 (9.9) | |
Duration on ART | Newly initiated on ART (ART naïve) | 567 (20.4) |
≤ 1 year of prior ART | 306 (11.0) | |
> 1 to < 2 Years of prior ART | 309 (11.1) | |
> 2 Years of prior ART | 1597 (57.5) | |